Pozen's Suit Over Treximet ANDAs Stays Intact
The judge overseeing Pozen Inc.'s bench trial against Par Pharmaceutical Cos. Inc., Mylan Inc.'s Alphapharm Pty. Ltd. and Dr. Reddy's Laboratories Inc. over generic versions of the migraine treatment Treximet denied...To view the full article, register now.
Already a subscriber? Click here to view full article